Eurofarma Laboratórios S.A. Share Price

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo Other stock markets			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Latest news : Eurofarma Laboratórios S.A.

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
21/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
14/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
13/08/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	22/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	22/11/2021

Director	Title	Age	Since
Marcelo Eduardo Martins BRD	Director/Board Member	58	22/11/2021
Maurízio Billi CHM	Chairman	-	22/11/2021
Cláudio Roberto Ely BRD	Director/Board Member	77	22/11/2021

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
10/01/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
04/12/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
04/12/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.14B 1.86B 1.74B 1.6B 3.02B 204B 3.05B 20.47B 8B 102B 8.05B 7.88B 338B	12.48B 2.44B 2.12B 1.97B 1.81B 3.43B 232B 3.47B 23.28B 9.1B 116B 9.16B 8.96B 384B
Net income	117M 22.92M 19.91M 18.56M 17.05M 32.24M 2.18B 32.6M 219M 85.54M 1.09B 86.09M 84.2M 3.61B	571M 112M 96.99M 90.43M 83.07M 157M 10.63B 159M 1.07B 417M 5.31B 419M 410M 17.6B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company

Income Statement and Estimates

More financial data